StockData
Citius Oncology, Inc. logo

Citius Oncology, Inc. (CTOR) stock

CTORNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$0.52−0.03 (-5.87%)

Close on Nov 12, 2026Market cap $48.56MP/E –Yield –

Citius Oncology gross margin

Gross margin is gross profit as a percentage of revenue.

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q3 FY2026CQ2 2026Jun 30, 202667.1%–
Q2 FY2026CQ1 2026Mar 31, 202680.3%–
Q1 FY2026CQ4 2025Dec 31, 202580.0%–

More Citius Oncology figures

See a number that looks wrong?